CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE
The article describes current views on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). Based on the findings of evidence-based medicine, an analytical description of all pl...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2017-05-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763075294494720 |
|---|---|
| author | A. V. Fonyakin L. A. Geraskina |
| author_facet | A. V. Fonyakin L. A. Geraskina |
| author_sort | A. V. Fonyakin |
| collection | DOAJ |
| description | The article describes current views on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). Based on the findings of evidence-based medicine, an analytical description of all platelet antiaggregants that have been clinically tested worldwide is presented. The benefits and shortcomings of each agent both in mono- and combination therapy are demonstrated. The novel ideas about rationality of the combination antiplatelet therapy with clopidogrel and acetylsalicylic acid in the first 24 hours lasting up to 90 days in patients with small ischemic stroke or TIA are highlighted. The effectiveness and safety of new platelet antiaggregants are analyzed. The key principles that guide the choice of antiplatelet agents in patients after ischemic non-car-dioembolic stroke are outlined. |
| format | Article |
| id | doaj-art-a00ff6ab98304950b3a19ceb6d9ffa20 |
| institution | DOAJ |
| issn | 2307-1109 2658-5952 |
| language | Russian |
| publishDate | 2017-05-01 |
| publisher | «REMEDIUM GROUP» Ltd. |
| record_format | Article |
| series | Атеротромбоз |
| spelling | doaj-art-a00ff6ab98304950b3a19ceb6d9ffa202025-08-20T03:05:31Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522017-05-010112313310.21518/2307-1109-2017-1-123-133109CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKEA. V. Fonyakin0L. A. Geraskina1Research Center of NeurologyResearch Center of NeurologyThe article describes current views on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). Based on the findings of evidence-based medicine, an analytical description of all platelet antiaggregants that have been clinically tested worldwide is presented. The benefits and shortcomings of each agent both in mono- and combination therapy are demonstrated. The novel ideas about rationality of the combination antiplatelet therapy with clopidogrel and acetylsalicylic acid in the first 24 hours lasting up to 90 days in patients with small ischemic stroke or TIA are highlighted. The effectiveness and safety of new platelet antiaggregants are analyzed. The key principles that guide the choice of antiplatelet agents in patients after ischemic non-car-dioembolic stroke are outlined.https://www.aterotromboz.ru/jour/article/view/115antiplatelet therapyischemic non-cardioembolic strokesecondary prevention |
| spellingShingle | A. V. Fonyakin L. A. Geraskina CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE Атеротромбоз antiplatelet therapy ischemic non-cardioembolic stroke secondary prevention |
| title | CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE |
| title_full | CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE |
| title_fullStr | CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE |
| title_full_unstemmed | CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE |
| title_short | CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE |
| title_sort | current views on antithrombotic therapy in non cardioembolic stroke |
| topic | antiplatelet therapy ischemic non-cardioembolic stroke secondary prevention |
| url | https://www.aterotromboz.ru/jour/article/view/115 |
| work_keys_str_mv | AT avfonyakin currentviewsonantithrombotictherapyinnoncardioembolicstroke AT lageraskina currentviewsonantithrombotictherapyinnoncardioembolicstroke |